{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:01:30Z","timestamp":1789988490805,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.psyneuen.2018.04.013","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T13:06:02Z","timestamp":1523624762000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Immune system and obsessive-compulsive disorder"],"prefix":"10.1016","volume":"93","author":[{"given":"Donatella","family":"Marazziti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-8237","authenticated-orcid":false,"given":"Federico","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9075-8226","authenticated-orcid":false,"given":"Leonardo F.","family":"Fontenelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2018.04.013_bib0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<151::AID-SYN8>3.0.CO;2-P","article-title":"Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity","volume":"35","author":"Albensi","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association Committee on Nomenclature and Statistics (APA)","year":"2014"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1176\/ajp.155.8.1122","article-title":"Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study","volume":"155","author":"Asbahr","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0025","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.04-1625fje","article-title":"Interleukin-6: a cytokine to forget","volume":"18","author":"Balschun","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/cyto.2001.0902","article-title":"Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter","volume":"14","author":"Bayley","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0035","first-page":"0","article-title":"Evaluation of a neuropsychiatric disorder: from PANDAS to PANS and CANS","volume":"27","author":"Baytunca","year":"2016","journal-title":"Turk. Psikiyatri Derg."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0040","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/npp.2009.77","article-title":"Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder","volume":"34","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(96)00495-7","article-title":"Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders","volume":"42","author":"Brambilla","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-1781(99)00091-8","article-title":"Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy","volume":"89","author":"Brambilla","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0055","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/WNL.0b013e3182181090","article-title":"Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome","volume":"76","author":"Brilot","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12868-016-0313-4","article-title":"Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder","volume":"17","author":"Cappi","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11065-006-9001-y","article-title":"Understanding obsessive-compulsive disorder: focus on decision making","volume":"16","author":"Cavedini","year":"2006","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference","volume":"25","author":"Chang","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0075","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pnpbp.2007.12.026","article-title":"Obsessive-compulsive disorder and immunology: a review","volume":"32","author":"da Rocha","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1440-1819.2007.01609.x","article-title":"Attention and cognition in patients with obsessive-compulsive disorder","volume":"61","author":"de Geus","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1017\/S1092852900023014","article-title":"Early onset obsessive-compulsive disorder with and without tics","volume":"14","author":"de Mathis","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0090","first-page":"785","article-title":"Post-streptococcal autoimmune disorders of the central nervous system","volume":"47","author":"Dale","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1381612822666151214104826","article-title":"Depression, serotonin and tryptophan","volume":"22","author":"Dell'Osso","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.psyneuen.2003.08.008","article-title":"Decreased TNF-alpha and NK activity in obsessive-compulsive disorder","volume":"29","author":"Denys","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"515","key":"10.1016\/j.psyneuen.2018.04.013_bib0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.mp.4001645","article-title":"Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder","volume":"10","author":"Dietrich","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2190\/F0BA-BN4F-61KA-UD99","article-title":"Obsessive-compulsive disorder and immunocompetence","volume":"31","author":"Dinn","year":"2001","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gepi.10252","article-title":"Pedigree disequilibrium tests for multilocus haplotypes","volume":"25","author":"Dudbridge","year":"2003","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0135","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.psyneuen.2009.12.005","article-title":"Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder","volume":"35","author":"Fluitman","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0140","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.comppsych.2011.12.007","article-title":"A cytokine study of adult patients with obsessive-compulsive disorder","volume":"53","author":"Fontenelle","year":"2012","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/cap.2014.0064","article-title":"PANDAS and comorbid Kleine-Levin syndrome","volume":"25","author":"Gerardi","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","article-title":"Systematic review of proinflammatory cytokines in obsessive-compulsive disorder","volume":"14","author":"Gray","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.ejhg.5201294","article-title":"Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort","volume":"13","author":"Haddy","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ajmg.10519","article-title":"Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands","volume":"114","author":"Hanna","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0028-1109420","article-title":"The relevance of the TNF-alpha system in psychiatric disorders","volume":"77","author":"Himmerich","year":"2009","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/brbi.2001.0645","article-title":"In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research","volume":"15","author":"Hinze-Selch","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/02646830500382003","article-title":"Tic disorders and obsessive-compulsive disorder: is autoimmunity involved?","volume":"17","author":"Hoekstra","year":"2005","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biopsych.2006.02.021","article-title":"Obsessive-compulsive spectrum disorders and rheumatic fever: a family study","volume":"61","author":"Hounie","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0185","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Janardhan Reddy","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0190","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","article-title":"IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis","volume":"115","author":"Kaplin","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.biopsych.2006.06.012","article-title":"Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with tourette syndrome: a preliminary study","volume":"61","author":"Kawikova","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/0264830500381435","article-title":"The immune system and neuropsychiatric diseases","volume":"17","author":"Kerr","year":"2005","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0205","doi-asserted-by":"crossref","first-page":"65704","DOI":"10.1155\/2007\/65704","article-title":"Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder","volume":"2007","author":"Konuk","year":"2007","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The \u2212308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0215","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","article-title":"Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome","volume":"57","author":"Leckman","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.31887\/DCNS.2006.8.2\/bleonard","article-title":"Changes in the immune system in depression and dementia: causal or coincidental effects?","volume":"8","author":"Leonard","year":"2006","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0225","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","article-title":"The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen","volume":"16","author":"Lestage","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0230","first-page":"164","article-title":"Cluster analysis of obsessive-compulsive symptomatology: identifying obsessive-compulsive disorder subtypes","volume":"45","author":"Lochner","year":"2008","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0006-3223(98)00131-0","article-title":"Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events","volume":"45","author":"Maes","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/0033-295X.105.1.83","article-title":"Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition","volume":"105","author":"Maier","year":"1998","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.2015.1005735","article-title":"Why have early investigational therapies of obsessive-compulsive disorder failed to materialise?","volume":"24","author":"Marazziti","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0250","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0006-3223(98)00371-0","article-title":"Immunological alterations in adult obsessive-compulsive disorder","volume":"46","author":"Marazziti","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0255","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0269881108089605","article-title":"Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder","volume":"23","author":"Marazziti","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0260","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.2174\/092986710793176384","article-title":"Past, present and future drugs for the treatment of obsessive-compulsive disorder","volume":"17","author":"Marazziti","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/138955710791112587","article-title":"Latest advancements on serotonin and dopamine transporters in lymphocytes","volume":"10","author":"Marazziti","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/IJICMR.S76710","article-title":"The cytokine profile of OCD: pathophysiological insights","author":"Marazziti","year":"2015","journal-title":"Int. J. Interferon Cytokine Mediator Res."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0275","article-title":"The glutamate and the immune systems: new targets for the pharmacological treatment of OCD","author":"Marazziti","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0280","article-title":"A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette's\/chronic tic disorders","author":"Mataix-Cols","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1176\/appi.ajp.2007.07020340","article-title":"Symptom structure in Japanese patients with obsessive-compulsive disorder","volume":"165","author":"Matsunaga","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0290","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1176\/appi.ajp.157.12.2036","article-title":"The psychiatric symptoms of rheumatic fever","volume":"157","author":"Mercadante","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0295","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/jnp.7.4.507","article-title":"Obsessive-compulsive disorder in patients with multiple sclerosis","volume":"7","author":"Miguel","year":"1995","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.psyneuen.2018.04.013_bib0300","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0305","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000026500","article-title":"Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder","volume":"37","author":"Monteleone","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.janxdis.2003.12.001","article-title":"Memory and attention in Obsessive-Compulsive Disorder: a review","volume":"19","author":"Muller","year":"2005","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0315","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archpedi.156.4.356","article-title":"Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS)","volume":"156","author":"Murphy","year":"2002","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0320","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.psc.2006.02.003","article-title":"Immunology of obsessive-compulsive disorder","volume":"29","author":"Murphy","year":"2006","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0325","series-title":"Janeway\u2019s Immunobiology","author":"Murphy","year":"2008"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0330","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/cap.2014.0062","article-title":"Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype","volume":"25","author":"Murphy","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/cap.2014.0010","article-title":"Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial","volume":"25","author":"Murphy","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0340","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2567.2001.01337.x","article-title":"Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production","volume":"104","author":"Nakae","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0345","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.111.092007","article-title":"Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study","volume":"200","author":"Nicholson","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0350","series-title":"Streptococcus Pyogenes: Basic Biology to Clinical Manifestations, Oklahoma City (OK)","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)","author":"Orefici","year":"2016"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2007.01.003","article-title":"Role of glutamate on T-cell mediated immunity","volume":"185","author":"Pacheco","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0360","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neubiorev.2016.09.025","article-title":"The link between autoimmune diseases and obsessive-compulsive and tic disorders: a systematic review","volume":"71","author":"Perez-Vigil","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0365","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0370","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0079-6123(07)63020-9","article-title":"Pro-inflammatory cytokines and their effects in the dentate gyrus","volume":"163","author":"Pickering","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0375","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000026545","article-title":"Prevalence of psychiatric disorders in thyroid diseased patients","volume":"38","author":"Placidi","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0380","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.molimm.2006.10.001","article-title":"Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever","volume":"44","author":"Ramasawmy","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0385","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/anxi.3070010203","article-title":"Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia","volume":"1","author":"Rapaport","year":"1994","journal-title":"Anxiety"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0390","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.biopsych.2005.12.012","article-title":"Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder","volume":"61","author":"Rauch","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(98)00072-X","article-title":"Circulating lymphocyte subsets in obsessive-compulsive disorder, major depression and normal controls","volume":"52","author":"Ravindran","year":"1999","journal-title":"J. Affect. Disord."},{"issue":"14","key":"10.1016\/j.psyneuen.2018.04.013_bib0400","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-017-1042-z","article-title":"Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder","volume":"28","author":"Rodr\u00edguez","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0405","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1176\/appi.ajp.158.11.1899","article-title":"Adults with early-onset obsessive-compulsive disorder","volume":"158","author":"Rosario-Campos","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0410","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuroscience.2009.10.043","article-title":"The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder: an integrative approach from genes to symptoms","volume":"165","author":"Rotge","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0415","first-page":"373","article-title":"Role of cytokines in inflammatory process in Parkinson's disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0420","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.psychres.2011.01.019","article-title":"A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder","volume":"189","author":"Sayyah","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0425","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","article-title":"Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease","volume":"216","author":"Scalzo","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0430","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1017\/S1092852900017090","article-title":"Anxiety disorders and rheumatic Fever: is there an association?","volume":"13","author":"Seixas","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0435","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-0035-1549929","article-title":"Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial","volume":"48","author":"Shalbafan","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0440","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4088\/JCP.15m10146","article-title":"Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder","volume":"77","author":"\u015eim\u015fek","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0445","article-title":"Cytokine, chemokine and BDNF levels in medicatio-free pediatric patients with obsessive-compulsive disorder","author":"Sivri","year":"2018","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresrev.2011.01.002","article-title":"Interleukin-6, a mental cytokine","volume":"67","author":"Spooren","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0455","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1176\/ajp.154.1.110","article-title":"Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever","volume":"154","author":"Swedo","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0460","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0465","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.1994.03520220082035","article-title":"Sydenham's chorea: a model for childhood autoimmune neuropsychiatric disorders","volume":"272","author":"Swedo","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0470","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000356554","article-title":"Searching for the immune basis of obsessive-compulsive disorder","volume":"21","author":"Teixeira","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0475","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3174\/ajnr.A3210","article-title":"Structural brain MR imaging changes associated with obsessive-compulsive disorder in patients with multiple sclerosis","volume":"34","author":"Tinelli","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0480","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/cap.2014.0063","article-title":"Disordered eating and food restrictions in children with PANDAS\/PANS","volume":"25","author":"Toufexis","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0485","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/da.20065","article-title":"Influence of age of onset on clinical features in obsessive-compulsive disorder","volume":"21","author":"Tukel","year":"2005","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0490","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-0039.1998.tb03056.x","article-title":"Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter","volume":"52","author":"Uglialoro","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0495","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","article-title":"Cytokines and cognition-the case for a head-to-toe inflammatory paradigm","volume":"50","author":"Wilson","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.psyneuen.2018.04.013_bib0500","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.gene.6363793","article-title":"Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE)","volume":"2","author":"Zuniga","year":"2001","journal-title":"Genes Immun."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018302841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018302841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:59:45Z","timestamp":1759683585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453018302841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":100,"alternative-id":["S0306453018302841"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.04.013","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune system and obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}